EPS rose 8.6% on margins, lower charge-offs & buybacks; 2026 is seen as flat with higher losses and risks. Read the full ...
Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) ("Satellos" or the "Company"), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, ...
Whitestone REIT (NYSE: WSR) (“Whitestone” or the “Company”) released the federal income tax treatment of 2025 cash ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results